title: Molecular events in relapsed oral squamous cell carcinoma: Recurrence vs. secondary primary tumor.
abstract: Relapses have a great impact on both the morbidity and mortality rates of oral squamous cell carcinoma (OSCC) patients. Current classification criteria are imprecise and need improvements. Recent advances in understanding of OSCC relapses on a molecular level provide new possibilities to better classify true recurrences and second primary tumors. This review discusses the limitations of the current OSCC relapse classification method and presents possible alternatives to improve this classification based on molecular techniques. Moreover, these molecular techniques add to the further understanding of these lesions and may provide tools for clinical management.
authors.affiliation: Laboratory of Medical Genomics, International Research Center, A. C. Camargo Cancer Center, São Paulo, Brazil.
authors.forename: Frederico O
authors.initials: FO
authors.lastname: Gleber-Netto
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: Boudewijn J M
authors.initials: BJ
authors.lastname: Braakhuis
authors.affiliation: Oral and Maxillofacial Pathology, School of Dentistry, University of Liverpool and Cellular Pathology, University Hospital Aintree, Liverpool, UK.
authors.forename: Asterios
authors.initials: A
authors.lastname: Triantafyllou
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
authors.forename: Robert P
authors.initials: RP
authors.lastname: Takes
authors.affiliation: Department of Head and Neck Surgery and Otorhinolaryngology, A. C. Camargo Cancer Center, São Paulo, Brazil.
authors.forename: Natalie
authors.initials: N
authors.lastname: Kelner
authors.affiliation: Department of Otolaryngology, Hospital Universitario Central de Asturias, University of Oviedo, Oviedo, Spain; Instituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain.
authors.forename: Juan P
authors.initials: JP
authors.lastname: Rodrigo
authors.affiliation: Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia.
authors.forename: Primož
authors.initials: P
authors.lastname: Strojan
authors.affiliation: Otorhinolaryngology-Head and Neck Surgery, Department of Oncology, Section Head and Neck Oncology, University Hospitals KU Leuven, Leuven, Belgium.
authors.forename: Vincent
authors.initials: V
authors.lastname: Vander Poorten
authors.affiliation: Department of Head and Neck Surgery, Greek Anticancer Institute, Saint Savvas Hospital, Athens, Greece.
authors.forename: Alexander D
authors.initials: AD
authors.lastname: Rapidis
authors.affiliation: University of Udine School of Medicine, Udine, Italy. Electronic address: alessandra.rinaldo@uniud.it.
authors.forename: Alessandra
authors.initials: A
authors.lastname: Rinaldo
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: Ruud H
authors.initials: RH
authors.lastname: Brakenhoff
authors.affiliation: Coordinator of the International Head and Neck Scientific Group.
authors.forename: Alfio
authors.initials: A
authors.lastname: Ferlito
authors.affiliation: Department of Head and Neck Surgery and Otorhinolaryngology, A. C. Camargo Cancer Center and National Institute of Science and Technology on Oncogenomics (INCITO), São Paulo, Brazil.
authors.forename: Luiz P
authors.initials: LP
authors.lastname: Kowalski
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000473:pathology*; D006258:Head and Neck Neoplasms / Q000235:genetics / Q000473:pathology; D006801:Humans; D009062:Mouth Neoplasms / Q000235:genetics / Q000473:pathology*; D009364:Neoplasm Recurrence, Local / Q000235:genetics / Q000473:pathology*; D016609:Neoplasms, Second Primary / Q000235:genetics / Q000473:pathology*
keywords: Molecular diagnosis; Oral cancer; Recurrence; Relapse; Second primary neoplasm; Squamous cell carcinoma